3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
4
Neoplasms
3
Lung Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Substance-Related Disorders
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Papillomavirus Infections
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Leukemia
1
HIV Infections
1
Death
1
Coitus
1
Interventions
Magnetic Resonance Spectroscopy
4
Surgical Procedures, Operative
3
Iodine-131
3
Iodine-124
3
Biopsy
3
selpercatinib
2
lenvatinib
2
Watchful Waiting
2
Thyrotropin Alfa
2
Therapeutics
2
Nivolumab
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Cetuximab
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
sintilimab
1
sacituzumab govitecan
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
defactinib
1
dabrafenib
1
cemiplimab
1
brodalumab
1
binimetinib
1
anlotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Thyroid Neoplasms
×
Focus Groups
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled